SEC 13F Intelligence

Duquesne Family Office LLC / PRCT

Duquesne Family Office LLC’s Procept Biorobotics Corp Position

Does Duquesne Family Office LLC own Procept Biorobotics Corp (PRCT)? Not currently — the last reported position was 39.3K shares worth $1M in Q2 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$1M
Q2 2022
Shares
39.3K
% of Portfolio
+0.09%
Quarters Held
4
position exited

Position History PRCT

Reported value by quarter
Q3 ’21: $23MQ3 ’21Q4 ’21: $42MQ4 ’21Q1 ’22: $39MQ1 ’22Q2 ’22: $1MQ2 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202239.3K$1M+0.09%
Q1 20221.13M$39M+1.71%
Q4 20211.66M$42M+1.51%
Q3 2021600.0K$23M+0.74%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of PRCT.